<code id='DB96588C00'></code><style id='DB96588C00'></style>
    • <acronym id='DB96588C00'></acronym>
      <center id='DB96588C00'><center id='DB96588C00'><tfoot id='DB96588C00'></tfoot></center><abbr id='DB96588C00'><dir id='DB96588C00'><tfoot id='DB96588C00'></tfoot><noframes id='DB96588C00'>

    • <optgroup id='DB96588C00'><strike id='DB96588C00'><sup id='DB96588C00'></sup></strike><code id='DB96588C00'></code></optgroup>
        1. <b id='DB96588C00'><label id='DB96588C00'><select id='DB96588C00'><dt id='DB96588C00'><span id='DB96588C00'></span></dt></select></label></b><u id='DB96588C00'></u>
          <i id='DB96588C00'><strike id='DB96588C00'><tt id='DB96588C00'><pre id='DB96588C00'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          hotspot